Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values With Evaluation of the Diagnostic Utility of Invasive Coronary Physiological Indices and Quantitative Perfusion MRI. The GzFFR Study

NCT02425969 is registered in ClinicalTrials.gov with Golden Jubilee National Hospital as lead sponsor.

NCT NCT02425969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02425969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values With Evaluation of the Diagnostic Utility of Invasive Coronary Physiological Indices and Quantitative Perfusion MRI. The GzFFR Study
Lead sponsor
Golden Jubilee National Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
October 1, 2016
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary physiology, grey-zone fractional flow reserve, intermediate coronary lesions, stable angina